Evidence map›Paper›PMID 23958448›Full record

ReviewNeuropharmacology2013

Active DNA demethylation in post-mitotic neurons: a reason for optimism.

David P Gavin, Kayla A Chase, Rajiv P Sharma

Abstract readReview
In one paragraph

Review in Neuropharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. TDP-43 Epigenetic Facets and Their Neurodegenerative Implications.International journal of molecular sciences · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David P GavinThe Psychiatric Institute, Department of Psychiatry, University of Illinois at Chicago, 1601 W. Taylor St., Chicago, IL 60612, USA; Jesse Brown Veterans Affairs Medical Center, 820 South Damen Avenue (M/C 151), Chicago, IL 60612, USA. Electronic address: dgavin@psych.uic.edu.
Kayla A ChaseThe Psychiatric Institute, Department of Psychiatry, University of Illinois at Chicago, 1601 W. Taylor St., Chicago, IL 60612, USA.
Rajiv P SharmaThe Psychiatric Institute, Department of Psychiatry, University of Illinois at Chicago, 1601 W. Taylor St., Chicago, IL 60612, USA; Jesse Brown Veterans Affairs Medical Center, 820 South Damen Avenue (M/C 151), Chicago, IL 60612, USA.

Funding

The H3K9 HISTONE SWITCH; 'LEVELS' IN SCHIZOPHRENIA BLOOD AND BRAINR01MH094358 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SHARMA, RAJIV PANDIT · 2012 to 2016
$2.3M
NIMH NIH HHS R01 MH094358
6 · The paper itself

Abstract

Over the last several years proteins involved in base excision repair (BER) have been implicated in active DNA demethylation. We review the literature supporting BER as a means of active DNA demethylation, and explain how the various components function and cooperate to remove the potentially most enduring means of epigenetic gene regulation. Recent evidence indicates that the same pathways implicated during periods of widespread DNA demethylation, such as the erasure of methyl marks in the paternal pronucleus soon after fertilization, are operational in post-mitotic neurons. Neuronal functional identities, defined here as the result of a combination of neuronal subtype, location, and synaptic connections are largely maintained through DNA methylation. Chronic mental illnesses, such as schizophrenia, may be the result of both altered neurotransmitter levels and neurons that have assumed dysfunctional neuronal identities. A limitation of most current psychopharmacological agents is their focus on the former, while not addressing the more profound latter pathophysiological process. Previously, it was believed that active DNA demethylation in post-mitotic neurons was rare if not impossible. If this were the case, then reversing the factors that maintain neuronal identity, would be highly unlikely. The emergence of an active DNA demethylation pathway in the brain is a reason for great optimism in psychiatry as it provides a means by which previously pathological neurons may be reprogrammed to serve a more favorable role. Agents targeting epigenetic processes have shown much promise in this regard, and may lead to substantial gains over traditional pharmacological approaches.

Indexed as

AnimalsBrainDNA MethylationDNA RepairEpigenesis, GeneticHumansNeuronsPsychotropic DrugsPsychotropic Drugs5CaC5-carboxylcytosine5FC5-formylcytosine5HMC5HMU5-hydroxymethylcytosine5-Hydroxymethylcytosine5-hydroxymethyluracil5MC5-methylcytosine5-Methylcytosineactivation-induced cytidine deaminaseAICDAAPE1APOBECapolipoprotein B mRNA editing enzyme, catalytic polypeptide-likeapurinic/apyrimidinic (AP) endonucleasebase excision repairBDNFBERbrain-derived neurotrophic factorcatechol-O-methyltransferaseCOMTCpGCpG methylationcytosine–phosphate–guaninedimethylated lysine 9 of histone 3DNA methyltransferaseDNMTECSelectroconvulsive seizureFGFfibroblast growth factorGGADD45growth arrest and DNA damageguanineH3K27H3K9me2HDAChistone deacetylaseKClLSD1lysine 27 of histone 3lysine-specific demethylase-1MBDMeCP2methyl-CpG binding domainmethyl CpG binding protein 2NERNMDAN-methyl d-aspartate receptor subtype 2BN-methyl-d-aspartic acidNR2Bnucleotide excision repairPARP1PFCPGCpoly ADP ribose polymerase-1potassium chloridePP1prefrontal cortexprimordial germ cellsprotein phosphatase 1single-strand selective monofunctional uracil-DNA glycosylase 1SMUG1TTDGten-eleven translocationTETthymidinethymine-DNA glycosylaseX-ray repair cross-complementing protein-1XRCC1

Identifiers

PMID23958448
PMCPMC3864977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.